Revolution Medicines(US:RVMD) Ge Long Hui·2026-01-09 09:49Core Viewpoint - Revolution Medicines (RVMD.US) shares surged 15.46% to $123.99 in pre-market trading following reports that Merck is in discussions to acquire the company for a price between $28 billion and $32 billion, potentially marking one of the largest pharmaceutical deals since Pfizer's $43 billion acquisition of Seagen at the end of 2023 [1]. Group 1: Company Performance - The closing price of Revolution Medicines on January 8 was $107.39, reflecting an increase of 4.56% [1]. - The pre-market price on January 9 reached $123.99, with a notable increase of $16.60 [1]. - The stock experienced a trading volume of 13.6073 million shares, with a total market capitalization of $20.761 billion [1]. Group 2: Market Metrics - The stock's highest price during the session was $112.43, while the lowest was $94.516 [1]. - The average price recorded was $102.925, with a price-to-earnings ratio indicating a loss [1]. - The stock's 52-week high was $112.43, and the 52-week low was $29.17 [1].